-
801
-
802
Ocular TGF-β, Matrix Metalloproteinases, and TIMP-1 Increase with the Development and Progression of Diabetic Retinopathy in Type 2 Diabetes Mellitus
Published 2021-01-01“…Diabetic retinopathy (DR) is a sight-threatening late complication of diabetes mellitus (DM). Even though its pathophysiology has not been fully elucidated, several studies suggested a role for transforming growth factor- (TGF-) β, matrix metalloproteinases (MMPs), and tissue inhibitors of matrix metalloproteinase (TIMP) in the onset and progression of the disease. …”
Get full text
Article -
803
-
804
Effect of Combination Therapy of Canagliflozin Added to Teneligliptin Monotherapy in Japanese Subjects with Type 2 Diabetes Mellitus: A Retrospective Study
Published 2020-01-01“…Recently, dipeptidyl peptidase-4 (DPP-4) inhibitors and sodium-glucose cotransporter 2 (SGLT2) inhibitors have been very often used in subjects with type 2 diabetes mellitus (T2DM). In addition, combination drugs of both inhibitors have attracted much attention in aspects of its cost-effectiveness and improvement of patients’ adherence. …”
Get full text
Article -
805
Modelo estadístico predictivo para el padecimiento de pie diabético en pacientes con diabetes mellitus tipo II
Published 2016-02-01Subjects: Get full text
Article -
806
Effect of Admission Hyperglycemia on Short-Term Prognosis of Patients with Non-ST Elevation Acute Coronary Syndrome without Diabetes Mellitus
Published 2021-01-01“…To evaluate the effect of admission hyperglycemia on the short-term prognosis of patients with non-ST elevation acute coronary syndrome (NSTE-ACS) without diabetes mellitus. Methods. The clinical data of 498 patients with NSTE-ACS admitted to the Department of Cardiology of the First Affiliated Hospital of Henan University of Science and Technology between March 2018 and November 2020 were analyzed. …”
Get full text
Article -
807
Use of Glucagon-Like Peptide-1 Receptor Agonists Does Not Increase the Risk of Cancer in Patients with Type 2 Diabetes Mellitus
Published 2025-01-01Subjects: “…diabetes mellitus, type 2…”
Get full text
Article -
808
Coronary Heart Disease in Postmenopausal Women with Type II Diabetes Mellitus and the Impact of Estrogen Replacement Therapy: A Narrative Review
Published 2014-01-01“…Coronary heart disease is the main cause of death in postmenopausal women (PMW); moreover its mortality exceeds those for breast cancer in women at all ages. Type II diabetes mellitus is a major cardiovascular risk factor and there is some evidence that the risk conferred by diabetes is greater in women than in men. …”
Get full text
Article -
809
-
810
Expression of atherosclerosis-associated genes in peripheral blood of drug-naïve hypertensive subjects with newly-diagnosed type 2 diabetes mellitus
Published 2025-02-01“…Aim: To evaluate the expression of atherosclerosis-associated genes in peripheral blood of drug-naïve hypertensive subjects with newly-diagnosed type 2 diabetes mellitus. Materials and methods: Eighteen subjects (15 males, 3 females), mean age 46.27 ± 12.07 years, divided into two groups: studied group - subjects with newly-diagnosed hypertension and newly-diagnosed type 2 diabetes (n = 9), control group – normotensive individuals with newly-diagnosed type 2 diabetes (n = 9) Gene expression analysis was performed with Human Atherosclerosis RT2 Profiler PCR Array. …”
Get full text
Article -
811
Correlation of Glucose and Lipid Metabolism Levels and Serum Uric Acid Levels with Diabetic Retinopathy in Type 2 Diabetic Mellitus Patients
Published 2022-01-01“…The aim of this study was to observe the association between the development of diabetic retinopathy (DR) in type 2 diabetes mellitus (T2DM) and the levels of glucose and lipid metabolism and serum uric acid (SUA) levels. …”
Get full text
Article -
812
Bridging the gap: access to health care and control of type 2 diabetes mellitus, hypertension and bronchial asthma among Egyptian women
Published 2025-02-01Subjects: Get full text
Article -
813
Changes of CA19-9 levels and related influencing factors in patients with type 2 diabetes mellitus after antidiabetic therapy
Published 2025-01-01Subjects: “…Type 2 diabetes mellitus…”
Get full text
Article -
814
-
815
Diabe-teach: a randomized controlled trial of a gamified approach to enhance medical undergraduates’ knowledge and comprehension of diabetes mellitus
Published 2025-01-01Subjects: “…Diabetes mellitus…”
Get full text
Article -
816
-
817
Effects of Semaglutide Treatment on Psoriatic Lesions in Obese Patients with Type 2 Diabetes Mellitus: An Open-Label, Randomized Clinical Trial
Published 2025-01-01“…The objective of this clinical study was to investigate the effect of GLP-1 receptor agonist semaglutide therapy on pro-inflammatory factors in the serum and the severity of the clinical picture of psoriasis in obese patients with type 2 diabetes mellitus (T2DM) on chronic metformin therapy. …”
Get full text
Article -
818
Glucometabolic-Related Genes as Diagnostic Biomarkers and Therapeutic Targets for Alzheimer’s Disease and Type 2 Diabetes Mellitus: A Bioinformatics Analysis
Published 2024-01-01“…Alzheimer’s disease (AD) and type 2 diabetes mellitus (T2DM) are two widespread chronic disorders characterized by shared risk factors and molecular pathways. …”
Get full text
Article -
819
-
820